301 related articles for article (PubMed ID: 32073669)
1. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
[TBL] [Abstract][Full Text] [Related]
2. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
[TBL] [Abstract][Full Text] [Related]
3. Dynamic rotating-shield brachytherapy.
Liu Y; Flynn RT; Kim Y; Yang W; Wu X
Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489
[TBL] [Abstract][Full Text] [Related]
4.
Adams Q; Hopfensperger KM; Kim Y; Wu X; Flynn RT
Med Phys; 2020 Dec; 47(12):6430-6439. PubMed ID: 33051866
[TBL] [Abstract][Full Text] [Related]
5. Interstitial rotating shield brachytherapy for prostate cancer.
Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
[TBL] [Abstract][Full Text] [Related]
6. Paddle-based rotating-shield brachytherapy.
Liu Y; Flynn RT; Kim Y; Dadkhah H; Bhatia SK; Buatti JM; Xu W; Wu X
Med Phys; 2015 Oct; 42(10):5992-6003. PubMed ID: 26429274
[TBL] [Abstract][Full Text] [Related]
7. Multihelix rotating shield brachytherapy for cervical cancer.
Dadkhah H; Kim Y; Wu X; Flynn RT
Med Phys; 2015 Nov; 42(11):6579-88. PubMed ID: 26520749
[TBL] [Abstract][Full Text] [Related]
8. A novel minimally invasive dynamic-shield, intensity-modulated brachytherapy system for the treatment of cervical cancer.
Morcos M; Antaki M; Viswanathan AN; Enger SA
Med Phys; 2021 Jan; 48(1):71-79. PubMed ID: 32916763
[TBL] [Abstract][Full Text] [Related]
9. Rotating-shield brachytherapy for cervical cancer.
Yang W; Kim Y; Wu X; Song Q; Liu Y; Bhatia SK; Sun W; Flynn RT
Phys Med Biol; 2013 Jun; 58(11):3931-41. PubMed ID: 23680601
[TBL] [Abstract][Full Text] [Related]
10. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy.
Liu Y; Flynn RT; Kim Y; Wu X
Med Phys; 2014 Nov; 41(11):111709. PubMed ID: 25370623
[TBL] [Abstract][Full Text] [Related]
12. SU-E-T-547: Rotating Shield Brachytherapy (RSBT) for Cervical Cancer.
Yang W; Kim Y; Liu Y; Wu X; Flynn R
Med Phys; 2012 Jun; 39(6Part18):3831. PubMed ID: 28518488
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Rotating Shield Brachytherapy for Prostate Cancer Dose Escalation and Urethral Sparing.
Adams Q; Hopfensperger KM; Kim Y; Wu X; Xu W; Shukla H; McGee J; Caster JM; Flynn RT
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1543-1550. PubMed ID: 30092333
[TBL] [Abstract][Full Text] [Related]
14. Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer.
Dadkhah H; Hopfensperger KM; Kim Y; Wu X; Flynn RT
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):719-728. PubMed ID: 28843372
[TBL] [Abstract][Full Text] [Related]
15. A novel
Famulari G; Duclos M; Enger SA
Med Phys; 2020 Mar; 47(3):859-868. PubMed ID: 31828783
[TBL] [Abstract][Full Text] [Related]
16. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
[TBL] [Abstract][Full Text] [Related]
17. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
[TBL] [Abstract][Full Text] [Related]
19. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
20. On the impact of absorbed dose specification, tissue heterogeneities, and applicator heterogeneities on Monte Carlo-based dosimetry of Ir-192, Se-75, and Yb-169 in conventional and intensity-modulated brachytherapy for the treatment of cervical cancer.
Morcos M; Viswanathan AN; Enger SA
Med Phys; 2021 May; 48(5):2604-2613. PubMed ID: 33619739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]